CTRI/2021/12/038587
Not yet recruiting
未知
A prospective, double blind, randomized clinical study to evaluate the antibody response after Covid-19 vaccine when provided along with NOQ19,an ayurvedic medicine
Sri Sri Institute of Advance Research SSIAR0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Sri Sri Institute of Advance Research SSIAR
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants yet to receive Covid\-19 vaccine
- •Residence within a 10\-kilometre radius of AIIMS hospital
Exclusion Criteria
- •Patients with associated comorbidities like hypertension, type 2 or type 1 diabetes or chronic or acute renal failure or any major systemic illness
- •Patients on Immuno\-suppression therapy
- •Pregnant Women or lactating mothers
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Antibody response after Covid-19 vaccine alongwith Kabasura KudineerCTRI/2021/05/033857Sri Sri Institute of Advance Research
Recruiting
Phase 1
A randomized, double-blind, prospective clinical study of Weiru Xitong ointment in the treatment of breast hyperplasiaBreast hyperplasiaITMCTR2000003364The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Completed
Not Applicable
Clinical trial to access change in gut immunity of healthy subjects for efficacy and safety of formulation (s).CTRI/2018/05/013813ITC Life Sciences and Technology Center250
Unknown
Not Applicable
A study to assess energy healing using prana as an add-on therapy for Anxiety.CTRI/2017/11/010646World Pranic Healing Foundation India11
Recruiting
Phase 1
A randomized, controlled, double-blind clinical study of Jiawei Qilang Decoction in the treatment of drug dependent constipatiodrug dependent constipationITMCTR2000003862Shanghai Municipal Hospital of Traditional Chinese Medicine